Eye Health Supplements Market

Eye Health Supplements Market Outlook (2023 to 2033)

The valuation of the global eye health supplements market stands at US$ 1.9 billion in 2023. Global demand for eye health supplements is forecasted to reach US$ 3.5 billion by the end of 2033, increasing at a CAGR of 6.2% over the forecast period (2023 to 2033).

Various prominent as well as regional manufacturers and government bodies are trying to increase awareness about eye health owing to the increasing aging population and rising prevalence of eye-related disorders globally. To reduce or minimize the cost of treatments, several public bodies are putting efforts to encourage people for the consumption of nutritional supplements and products. They are used as maintenance and preventive medicine for eye health.

Growing prevalence of eye disorders, especially in the elderly population, is predicted to fuel demand for eye health supplements. Various eye problems occur due to aging and therefore appropriate treatment and precautionary medicines for maintaining eye health are required. The utilization of eye health products, including supplements, is an effective way to treat different eye issues, which arise due to aging.

• Based on indication, age-related macular degeneration accounted for 32% revenue share of the global market in 2022.

The appropriate use of eye health supplements is helpful to treat various disorders, including cataracts, macular degeneration retinopathy, trachoma, optic neuritis, dry eye syndrome, and infections. Moreover, rising cases of vision impairment along with the increasing prevalence of myopia are due to growing screen time along with engagement in virtual meetings while working from home.

High myopia is related to the increased risk of various degenerative eye diseases, including glaucoma and cataracts. The target industry is also driven by the growing preference for different eye health supplements among millennials, who are more susceptible to digital eye fatigue and myopia.

Stringent regulations surrounding product safety, manufacturing, and efficacy claims are expected to hamper market expansion over the forecasted period. There are regional differences in regulations. Some regions do not permit health benefit claims, whereas some do. Therefore, these factors are expected to directly impact product demand.

Fact.MR, a provider of market research and competitive intelligence, provides a holistic analysis of the global eye health supplements market. The newly published research report has a detailed analysis of growth opportunities, key trends, regional overview, competitive landscape, and other aspects.

Report Attributes	Details
Market Size in 2023	US$ 1.9 Billion
Forecasted Market Value (2033)	US$ 3.5 Billion
Global Market Growth Rate (2023 to 2033)	6.2% CAGR
Revenue Share of Lutein & Zeaxanthin (2022)	32%
Revenue Share of Tablets (2022)	41%
Key Companies Profiled	The Nature’s Bounty Co. Pfizer Inc. Vitabiotics Ltd. Bausch & Lomb Kemin Industries, Inc. Amway International EyeScience Wellbeing Nutrition Nutrivein ZeaVision LLC Nutrachamps Kemin Industries, Inc.

Which Determinants are Contributing to Rising Demand for Eye Health Supplements?

“Increasing Cases of Vision Impairment Among Global Population”

There has been a significant increase in the incidence of vision impairment among people around the world, which is expected to boost the demand for eye health supplements.

For instance :

• According to the data provided by World Health Organization in October 2020, around one billion around the world were suffering from vision impairment.

Vision impairment is caused owing to multiple reasons, including congenital and hereditary abnormalities, toxicosis, injuries to the eyes, and acquired eye diseases, including trachoma, glaucoma, cataract, optic neuropathy, disorders of the cornea, ametropia, disorders of retina and choroid, amblyopia, and others. Therefore, rising cases of eye-related disorders around the world are projected to generate demand for eye health supplements, which can help in the effective functioning of the eyes.

“R&D Activities and Product Approvals - Opening New Avenues for Suppliers of Eye Health Supplements”

Increasing concentration on the development of supplements is expected to bolster growth opportunities in the target market.

For instance :

• Atlas Nanotech is a company operating in nanotechnology research and development and is a subsidiary of COSTAS, Inc. The company is concentrating on nanomedicine. In January 2019, the company announced the completion of the first-ever nanotechnology vitamin A (retinol)-based crystalline eye drop. This product is planned to be sold under NANO CLEAR A trade name and is indicated for dry eye diseases.

Which Factors are Negatively Impacting Eye Health Supplements Market Expansion?

“Implementation of Stringent Regulations for Production of Eye Health Supplements”

Certain stringent regulations are imposed by governing bodies to produce eye health supplements, which is estimated to limit market growth.

For instance :

• In June 2020, the Food Safety and Standards Authority of India alerted food safety commissioners of all Indian states to ensure the RDA (recommended dietary allowances) values of health supplements, which include eye health supplements, including amino acids, minerals, and vitamins in food products. These values should not be exceeded in products for the Indian population.

A lack of knowledge or ignorance of these values is anticipated to have adverse impacts on the quality and demand for final products and therefore expansion opportunities are also restricted.

“Dearth of Facilities for Identification of Dry Eye Disease in Developing Economies”

There is no single authentic test available for the diagnosis of dry eye diseases among people from developing economies. Therefore, sometimes it becomes difficult to diagnose diseases, which are predicted to have a direct impact on the demand for eye health supplements.

How are New Market Entrants Transforming the Eye Health Supplements Landscape?

“Product Launches - Key to Eye Health Supplements Market Expansion”

New players, who are exploring avenues in the global market are investing a significant amount of money in product innovation to provide more effective supplements.

For instance :

• Nippon Flour Mills is a Japan-based company. In August 2019, the company entered into the healthcare domain with the launch of brain and eye supplements, which are made from lutein and zeaxanthin.

Why are Manufacturers of Eye Health Supplements Looking to Invest in North America?

“Rising Cases of Eye Disorders in the Region”

Rising geriatric population, growing cases of diabetes, and different eye disorders, including cataracts, diabetic retinopathy, AMD (age-related macular degeneration), and other eye diseases are predicted to boost growth opportunities in North America. Macular degeneration, which is generally addressed as AMD, is an eye disorder related to aging and further results in damaged central and sharp vision.

• Macular degeneration, according to Macular Degeneration Research 2021, is considered a prominent reason for vision loss among Americans who are of 60 years and more.

Age is a significant risk factor for macular degeneration. The risk to get advanced AMD can increase from 2% for people aged 50-59 to 30% who are above the age of 75. Moreover, increased investment along with new product launches by key players in North America is predicted to aid market growth.

For instance :

• In July 2019, Bausch and Lomb launched Ocuvite Eye Performance, which is a vitamin supplement for eye health. It is produced with seven crucial nutrients, which are helpful in strengthening the macula.

Players operating in the region are investing in R&D activities, acquisitions, and collaborations to expand their product portfolio.

For instance :

• In November 2019, Zea Vision LLC entered into a partnership with the Boston Red Sox as an official brand for eye vitamins.

Country-wise Insights

What Makes the United States a Hub for Eye Health Supplements?

“Increased Cases of Eye Disorders Bolstering Demand for Eye Nutrition Supplements”

• According to CDC (Centers for Disease Control and Prevention), eye disorders or diseases are very common in the United States. Around 4.2 million Americans, who are of 40 years and above either have low vision or are blind.

Cataracts, age-related macular degeneration, amblyopia, and glaucoma are some major disorders or diseases, which are found in Americans. Red eyes, eye strain, lazy eyes, night blindness, etc., are symptoms of eye health disorders or diseases. Ophthalmologists prescribe eye health supplements, including zinc, lutein and zeaxanthin, vitamin C, omega-3 fatty acids, and vitamin B1, which is predicted to boost their sales in the United States.

Why are Manufacturers of Eye Health Supplements Investing in Germany?

“Increased R&D Activities for Production of Effective Eye Health Supplements”

Germany held 5.2% share of global revenue in 2022. Increased R&D activities, growing requirements for innovative and more effective eye health products, and the rapidly developing insurance sector are projected to generate growth opportunities. The availability of an efficient supply chain management system in Germany is also contributing to revenue share.

Category-wise Insights

Which Ingredients are Widely Used in Eye Health Supplement Production?

“Rising Awareness about Benefits of Lutein & Zeaxanthin Supplements for Eye Disorders”

Lutein and zeaxanthin, omega-3 fatty acids, antioxidants, coenzyme Q10, flavonoids, alpha-lipoic acid, astaxanthin, and others are key ingredients used in the production of eye health supplements. Among these, lutein and zeaxanthin ingredients are used significantly in eye health supplements. The segment held around 32% of the global revenue in 2022.

Growing awareness about the benefits of lutein and zeaxanthin supplements to prevent and provide effective treatment against different eye disorders, especially diabetic retinopathy, cataract, uveitis, and AMD is contributing to their increased demand. In addition, the increasing prevalence of eye disorders and recommendations for eye health supplements by clinicians, vision scientists, and ophthalmologists are driving market growth.

Which Indication is Stimulating High Demand for Eye Health Supplements?

“Age-related Macular Degeneration - Most Common Reason for Blindness”

Based on indication, the global industry is classified into age-related macular degeneration, cataract, dry eye syndrome, inflammation, and others. Age-related macular degeneration held a 32% share of the global revenue in 2022. The increasing global prevalence of age-related macular degeneration is contributing to market growth.

AMD is reported as the third most vital reason for blindness across the globe. It further leads to blindness among higher-income countries with a significant aging population.

• According to BrightFocus Foundation, approximately 11 million people from the United States encountered some form of AMD in 2019, which is expected to reach around 22 million by the end of 2050. The number of patients experiencing macular degeneration, globally, was 196 million in 2020 and is forecasted to reach 288 million by the end of 2040.

What Makes Tablet-based Eye Health Supplements Popular among Patients?

“Easy and High Availability of Supplements in Tablet Formulation”

Tablets, capsules, powder, softgels, and liquid are the key forms in which eye health supplements are available across the globe. Among these, tablet-based eye health supplements held 41% of the global market revenue in 2022. Increasing preference for tablet-based eye health supplements due to their easy and high availability in different forms, including sublingual and buccal tablets, sustained-release tablets, and chewable tablets is boosting their sales.

Tablets are comparatively cheaper than other formulations. Moreover, patients from different age groups are widely accepting these forms, which is predicted to contribute to their rising demand. The longer shelf-life of tablets compared to liquid and powder forms is also stimulating their sales.

Demand for softgel-based eye health supplements is expected to increase at a noteworthy rate. Softgels are considered an effective form of eye health supplement. Researchers advocate the effectiveness of supplements in native form compared to modified forms.

Key Market Players

Top brands producing eye health supplements are investing in the improvisation of their systems used for supply chain management. Companies are investing a significant amount in new developments to offer more qualitative products to end users with a variety of flavors. Moreover, governing bodies are implementing regulatory frameworks to reduce environmental impacts and to ensure the availability of quality products in the global market.

Prominent players are focusing on the development of more efficient eye health supplements to gain lucrative opportunities in the market.

For instance :

• In April 2022, Wellbeing Nutrition released ‘Melts Eye Care’, which is the first all-natural eye vitamin in the world. This internationally recognized brand uses advanced nanotechnology for the delivery of vitamins directly into the bloodstream. It makes the bloodstream more bioactive and bioavailable compared to conventional capsules and tablets.
• In October 2020, Nature’s Way invested in the manufacturing of supplements for kids to ensure better health for them. The company announced the launch of dietary supplements, which can cater to the health requirements of children. Nature’s Way Healthy Eyes is a supplement for better functioning and health of the eyes.

The Nature’s Bounty Co., Pfizer Inc., Vitabiotics Ltd., Bausch & Lomb, Amway International, EyeScience, Nutrivein, ZeaVision LLC, Nutrachamps, and Kemin Industries, Inc. are key suppliers of eye health supplements.

Segmentation of Eye Health Supplements Industry Research

• By Ingredient :

  • Lutein and Zeaxanthin
  • Omega-3 Fatty Acids
  • Antioxidants
  • Coenzyme Q10
  • Flavonoids
  • Alpha-lipoic Acid
  • Astaxanthin
  • Others

• By Indication :

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye syndrome
  • Inflammation
  • Others

• By Formulation :

  • Tablets
  • Capsules
  • Powder
  • Softgels
  • Liquid

• By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa